Suzuken Co Ltd
TSE:9987
Suzuken Co Ltd
TSE:9987
Price:
4 547 JPY
-1.17%
Market Closed
Updated:
Apr 18, 2024
P/B
Price to Book Value
Price to Book Value
0.9
Current
0.8
Median
2.3
Industry
Higher
than median
Lower
than industry value
Price to Book Value (P/B) ratio is a valuation multiple that measures the market's valuation of a company relative to its book value. The P/B ratio is only considered useful in practice when applied to capital-intensive businesses.
P/B
=0.9
Market Cap
/
356.8B
Book Value of Equity
410.8B
All Countries
| Market Cap | P/B | ||||
|---|---|---|---|---|---|
| JP |
|
Suzuken Co Ltd
TSE:9987
|
356.8B JPY | 0.9 | |
| US |
|
Mckesson Corp
NYSE:MCK
|
68.9B USD | -33.6 | |
| US |
|
Cencora Inc
NYSE:COR
|
47.6B USD | 52.2 | |
| US |
|
Amerisourcebergen Corp
NYSE:ABC
|
35.4B USD | 51.5 | |
| US |
|
Cardinal Health Inc
NYSE:CAH
|
26B USD | -7.5 | |
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
9.1B USD | 2.5 | |
| KR |
C
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW | 6 | |
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
61.9B HKD | 0.8 | |
| IT |
|
Amplifon SpA
MIL:AMP
|
7B EUR | 6.3 | |
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
53.6B CNY | 2.7 | |
| CN |
S
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
50B CNY | 0.7 |
P/B Forward Multiples
Forward P/B multiple is a version of the P/B ratio that uses forecasted equity for the P/B calculation. 1-Year, 2-Years, and 3-Years forwards use equity forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
P/B
N/A
2-Years Forward
P/B
N/A
3-Years Forward
P/B
N/A
You don't have any saved screeners yet
